Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
CD Protein Inhibitors
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Zinbryta
(daclizumab) / Biogen, AbbVie
Epratucyn
(epratuzumab) / Gilead
Simulect
(basiliximab) / Novartis
Ocrevus
(ocrelizumab) / Roche
otelixizumab
(ChAglyCD3) / GSK
Arzerra
(ofatumumab) / Novartis, Genmab
Tzield
(teplizumab-mzwv) / Sanofi
HuMax-CD4
(zanolimumab) / Emergent Biosolutions
Lupuzor
(rigerimod) / ImmuPharma, Alora Pharma
